Published in:
Open Access
01-12-2015 | Meeting abstract
A collaborative opioid prescribing (CoOP) model linking opioid treatment programs with office-based buprenorphine providers
Author:
Kenneth B Stoller
Published in:
Addiction Science & Clinical Practice
|
Special Issue 1/2015
Login to get access
Excerpt
Despite abundant research demonstrating good efficacy, pharmacotherapies for substance use disorders are underutilized. Buprenorphine holds promise to significantly increase the availability of medication-assisted therapy for opioid use disorder; yet despite dramatic increases in overdose deaths driven largely by prescription opioid use, only about half of DATA-waivered physicians prescribe buprenorphine. …